Company: RNAC
Filing Date: 2025-12-18
Form Type: 8-K
Source: 0001453687-25-000140
Chunk: 2

Company: Cartesian Therapeutics, Inc.
Filing Date: 2025-12-18
Form: 8-K
Item: Item 5.05
Chunk 2
---
Item 5.05 Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics.

On December 16, 2025, the Board adopted an updated version of the Cartesian Therapeutics, Inc. Code of Business Conduct and Ethics (the “ Code”), effective as of such date. The Code supersedes and replaces the Company’s prior Code of Business Conduct and Ethics (the “ Prior Code”).

The Code applies to all directors, officers and employees of the Company and its subsidiaries and is intended to enhance understanding of the Company’s standards of ethical business practices and promote awareness of ethical issues that may be encountered in carrying out a director’s, officer’s or employee’s responsibilities. In addition, the Code is intended to constitute the Company’s “code of ethics” within the meaning of Section 406 of the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Securities and Exchange Commission thereunder.

Among other things, the Code:

• updates and clarifies the Company’s requirements regarding the protection and proper use of Company assets and information, including requirements applicable to employees who use personal mobile phones, tablets, computers or other personal devices for Company business (bring-your-own-device or “ BYOD”), including compliance with Company BYOD and information security policies and the Company’s ability, to the extent permitted by law, to access, preserve, or remotely remove Company data from such devices; and

• makes various other updates, including clarifying, ministerial and conforming changes.

The adoption of the Code did not result in any explicit or implicit waiver of any provision of the Prior Code.

The foregoing description of the Code does not purport to be complete and is subject to and qualified in its entirety by reference to the full text of the Code, a copy of which is filed as Exhibit 14.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 7.02 Regulation FD Disclosure.